Asia Pacific clinical nutrition market will grow by 9.2% annually with a total addressable market cap of $328.51 billion over 2023-2032. The growth is driven by the increasing incidence of malnutrition, the rising prevalence of chronic diseases, the growing awareness pertaining to health and fitness among people, and the higher number of premature births.

Highlighted with 68 tables and 77 figures, this 155-page report “Asia Pacific Clinical Nutrition Market 2022-2032 by Substrate, Administration Route (Oral or Enteral, Parenteral), Dosage Form (Powder, Liquid, Solid), Therapeutic Area, End User (Infant, Children, Adult, Geriatrics), Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces


The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific clinical nutrition market in every aspect of the classification from perspectives of Substrate, Administration Route, Dosage Form, Therapeutic Area, End User, Healthcare Setting, Distribution Channel, and Country.

Based on Substrate, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Carbohydrates
  • Lipids
  • Proteins & Amino Acids
  • Water & Electrolyte
  • Dietary Fiber
  • Antioxidants
  • Other Substrates



Based on Administration Route, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Oral or Enteral Administration
    • Oral Nutrition Supplements
    • Tube Feeding
  • Parenteral Administration
    • Supplemental Parenteral Nutrition
    • Total Parenteral Nutrition
    • All-in-One System
    • Multiple Bottle System


By Dosage Form, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Powder
  • Liquid
  • Solid and Semi-solid



By Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Malnutrition
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Cancer
  • Neurology
  • Renal Diseases
  • Respiratory Diseases
  • Other Therapeutic Areas



By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Infant
  • Children
  • Adult
  • Geriatrics



By Healthcare Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Hospitals
  • Long-term Care Facilities (LTC)
  • Homecare
  • Inpatient Rehabilitation Facilities
  • Other Healthcare Settings



By Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Institutional Sales
  • Supermarkets & Hypermarkets
  • Pharmacies
  • Drug Stores
  • Online Channels
  • Other Distribution Channels



Geographically, the following national/local markets are fully investigated:

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)


For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Administration Route, Therapeutic Area, and End User over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • Abbott Nutrition
  • B Braun Melsungen Ag
  • BASF SE
  • Baxter International Inc.
  • Claris Lifesciences Ltd.
  • Fresenius Kabi Ag
  • Lonza Group AG
  • Nestl? S.A.
  • Nutricia Ltd
  • Perrigo Company Plc

(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)